Why Compass Pathways Stock Rocketed 40% Today

Compass Pathways may be the first to benefit from an accelerated approval process.
Fierce Biotech

Compass, Usona and Transcend score FDA national priority vouchers amid Trump administration’s psychedelic push

The FDA is awarding national priority vouchers to Compass Pathways and the Usona Institute as the Trump administration looks ...

How Compass’ market share exploded post-merger

The Consumer Policy Center estimated that Compass’ market share was up to 40 percent after its deal for Anywhere Real Estate.
National Mortgage Professional

What Rocket And Compass Are Really Telling You About The Future Of Mortgage Distribution

Before we talk about Rocket and Compass, we need to talk about OriginPoint. In 2021, Compass and then Guaranteed Rate (now ...
Las Vegas Sun

Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...

B. Riley Raises its Price Target on Compass Diversified (CODI) to $10.50

On April 6, 2026, B. Riley analyst Timothy D’Agostino raised the price target on Compass Diversified (NYSE:CODI) to $10.50 ...
The Barre-Montpelier Times Argus

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the ...